ArticleAdvanced functional materials2026
Controlling Payload Heterogeneity in Lipid Nanoparticles for RNA-Based Therapeutics.
Article in Advanced functional materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Polymeric mesoscale nanoparticles exhibit dynamin- and macropinocytosis-dependent endocytosis.Nanomedicine : nanotechnology, biology, and medicine · 2026Article
- Single-Particle Analysis of Cargo-Dependent Deformation in Lipid Nanoparticles Using Resistive Pulse Sensing: Implications for Formulation Optimization and Quality Control of mRNA Nanomedicine.ACS applied nano materials · 2026Article
- Functionalized Lipid Nanoparticles for Targeted RNA Delivery in Immune and Inflammatory Diseases.Biomedicines · 2026Review
- Endocytosis of PEGylated polymeric mesoscale nanoparticles is dynamin- and macropinocytosis-dependent.bioRxiv : the preprint server for biology · 2026Article
- Lipid nanoparticles and extracellular vesicles: emerging cell free therapeutic platforms for hepatobiliary cancers.Frontiers in cell and developmental biology · 2026Review
- Viscosity of concentrated mRNA solutions: Implications for downstream processing.Biotechnology progressArticle
Corrections and comments
- Update of
Authors and funding
6 authors.
Funding
Abstract
Lipid nanoparticles (LNPs) are a leading platform for nucleic acid delivery, yet conventional assembly by mixing lipids with RNA yields particles with heterogeneous, bimodal payload distribution. Our transfection experiments demonstrate that heterogeneous siRNA distribution within LNPs significantly reduces gene knockdown efficiency. To systematically investigate the origin and extent of payload heterogeneity, we integrate coarse-grained molecular dynamics and kinetic Monte Carlo simulations with single-particle characterization via cylindrical illumination confocal spectroscopy and machine learning analysis. We find that the balance between RNA diffusion kinetics and lipid self-assembly dynamics is the dominant driver of payload heterogeneity. Leveraging this mechanistic insight, we show that (i) finely controlled turbulent mixing minimizes payload variance and increases the uniformity of RNA distribution without altering LNP size, and (ii) systematic adjustment of salt concentration and PEG-lipid content tunes RNA loading in a volume-dependent manner. Together, these results elucidate the self-assembly landscape of RNA-LNPs and provide actionable design principles for crafting more uniform, potent, and safer LNP-based nucleic acid therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.